CT-guided Percutaneous Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 主要终点
- Overall Survival (OS)
研究概览
简要总结
(MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.
详细描述
From June 2010 to June 2015, 48 unresectable lesions in 32 patients with pulmonary metastases from colorectal cancer were selected for CT-guided microwave ablation. Patients were scheduled for a 1 and 3 month CT follow-up to evaluate lesion diameter.We retrospectively evaluated CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Unresectable pulmonary metastases from colorectal cancer.
- •diagnosis by CT, and confirmed by percutaneous puncture biopsy.
- •Age range 18-70 years old.
- •Eastern Cooperative Oncology Group performance status 0-
- •Life expectancy of more than 3 months.
- •Adequate organ function.
排除标准
- •Resectable lung metastases.
- •Life expectancy less than 3 months
- •Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials.
- •Coagulopathy with platelet count less than
- •Active infectious disease.
- •Age below 18 years.
- •Pregnancy of breastfeeding.
研究组 & 干预措施
Treated with microwave ablation
Patients undergoing MWA for pulmonary metastases from colorectal cancer.
干预措施: microwave ablation (Device)
结局指标
主要结局
Overall Survival (OS)
时间窗: one year
次要结局
- Treatment related adverse events(Eight weeks)